Mankind Pharma Limited — Important, 17-07-2025: General Updates

The company is ensuring broad shareholder access to critical information. Letters have been dispatched to investors without registered emails, providing a direct weblink to the FY 2024-25 Annual Report and the notice for the upcoming Annual General Meeting (AGM). The AGM is scheduled to be held via virtual means, facilitating participation. This proactive step helps all shareholders stay informed and prepared for key company discussions.